Design and Implementation of an Opt-Out, End-to-End, Preemptive DPYD Testing Program for Patients Planned for a Systemic Fluoropyrimidine.

Joseph O Jacobson Garrett RompelmanAngela ChenSamantha Morrison-MaLindsay MurrayMaria FerzocoCraig BunnellAndrew J Wagner Daniel Aaron RobertsJennifer ChanCaroline BlockDouglas Rubinson

Published in: JCO oncology practice (2024)

testing is feasible, and high rates of testing can be achieved using an opt-out, reminder-based program. We provide the details of the implementation and encourage others to emulate it.

Keyphrases

quality improvement
end stage renal disease
primary care
healthcare
ejection fraction
newly diagnosed
chronic kidney disease
peritoneal dialysis
prognostic factors
patient reported outcomes